Mendelspod
Subscribe
Sign in
Home
Archive
About
Latest
Top
Discussions
CareDx’s Second Act with CEO John Hanna
CareDx is a company on the move.
Feb 17
•
Theral Timpson
1
1
37:55
Inside GP2: Building a Global Genetic Map of Parkinson’s with Andrew Singleton and Ignacio Mata
Large-scale genomics is back.
Feb 10
•
Theral Timpson
2
1
40:44
A Simple Sponge, a Big Shift in Cell Therapy with Yev Brudno, UNC
What if the hardest part of scaling cell therapy turned out to be a materials problem not a biological one—and the solution looked like a sponge?
Feb 3
•
Theral Timpson
1
1
30:39
January 2026
How Cellanome Is Changing the Way We Study Cell Function with Matthew Spitzer and Pier Federico Gherardini
For today’s show, we return to discussing the exciting new Cellanome platform.
Jan 29
•
Theral Timpson
1
1
23:56
From Hereditary Risk to Residual Disease: Natera’s Integrated Vision for Precision Oncology with Adam ElNaggar, MD
Half of oncologists in the U.S.
Jan 28
•
Theral Timpson
1
1
41:58
The Rise of Geroscience with Alan Landay and Tom Blackwell, UTMB
Aging may be the last great frontier of precision medicine—not a single disease, but the slow re-patterning of immunity, metabolism, and resilience that…
Jan 22
•
Theral Timpson
1
1
46:16
Unlocking the RNA Revolution: How Self-Replicating RNA Could Transform Vaccines and Therapeutics with Andrew Geall, Replicate Bioscience
The RNA revolution didn’t end with COVID.
Jan 15
•
Theral Timpson
3
1
33:41
From Targets to Hits: The Emerging AI Ecosystem in Drug Discovery with Aqib Hasnain, Mithrl and Cheng Hu, Technetium Therapeutics
Perhaps more than in any other field, AI is impacting drug discovery and development.
Jan 9
•
Theral Timpson
2
34:10
December 2025
Most Popular Show of 2025: How Certis Is Rewriting Cancer Models with CEO Peter Ellman
In our most listened to episode this year, Certis Oncology CEO Peter Ellman breaks down how his company is reinventing cancer research by building…
Dec 30, 2025
•
Theral Timpson
2
1
38:30
Building the Front-End for Every Sequencer with Volta Labs CEO Udayan Umapathi
As sequencing continues to become cheaper, more attention is being paid to sample prep.
Dec 18, 2025
•
Theral Timpson
1
1
26:48
A New Foundational Platform for Biology: Cellanome’s Debut with CEO Omead Ostadan
Few startups have launched with such quiet anticipation—or such a remarkable founding pedigree—as Cellanome. Backed by veterans of the genomics…
Dec 17, 2025
•
Theral Timpson
2
1
42:06
The Best of Times, the Worst of Times: Former NHGRI Director Eric Green on a Shaken NIH and Surging Genomic Science
At the end of each year we look for a guest who in many ways defines the year.
Dec 11, 2025
•
Theral Timpson
4
1
2
50:26
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
